HER2 Support Group Forums - View Single Post - putting risk of brain mets as first evidence of recurrence in perspective

R.B. · 05-28-2006, 07:55 AM

Some more data on brain tumour figures.

Not the most cheerful of reading.

From Lani's post early BC follow up median 13 years no chemo no herceptin - Risk less than 2-5%.

From below metastic BC - treatment status unknown - follow up period unknown 10-15%

HER 2 - threatment status unknown - follow up unknown 25-35%.

I will try and see what else I can find.

Can anybody add to this?

RB

http://www.azcentral.com/health/wome...survivors.html

ABSTRACT

.................About 150,000 Americans a year are diagnosed with "metastatic" brain tumors, meaning the cancer has spread from another location, usually their lungs or breasts. The chances that a woman with metastatic breast cancer will develop brain tumors is 10 to 15 percent. But these odds appear to be worse for a woman such as Soscia, whose breast cancer has a genetic mutation known as HER2-positive that makes it very aggressive. Twenty-five to 35 percent of women with metastatic HER2-positive cancer end up with brain cancer, Winer said...............

05-28-2006, 07:55 AM	#10
R.B. Senior Member Join Date: Mar 2006 Posts: 1,843	A new peril for breast cancer survivors Boston Globe Some more data on brain tumour figures. Not the most cheerful of reading. From Lani's post early BC follow up median 13 years no chemo no herceptin - Risk less than 2-5%. From below metastic BC - treatment status unknown - follow up period unknown 10-15% HER 2 - threatment status unknown - follow up unknown 25-35%. I will try and see what else I can find. Can anybody add to this? RB http://www.azcentral.com/health/wome...survivors.html ABSTRACT .................About 150,000 Americans a year are diagnosed with "metastatic" brain tumors, meaning the cancer has spread from another location, usually their lungs or breasts. The chances that a woman with metastatic breast cancer will develop brain tumors is 10 to 15 percent. But these odds appear to be worse for a woman such as Soscia, whose breast cancer has a genetic mutation known as HER2-positive that makes it very aggressive. Twenty-five to 35 percent of women with metastatic HER2-positive cancer end up with brain cancer, Winer said...............